Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma

Thymic carcinoma (TC) is a rare cancer with minimal evidence of survival following palliative‐intent chemotherapy. Sunitinib, everolimus, and pembrolizumab have been proposed as active agents based on previous phase II trials. In this phase II study, TC patients previously treated with platinum‐base...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Med
Asıl Yazarlar: Okuma, Yusuke, Goto, Yasushi, Ohyanagi, Fumiyoshi, Sunami, Kuniko, Nakahara, Yoshiro, Kitazono, Satoru, Kudo, Keita, Tambo, Yuichi, Kanda, Shintaro, Yanagitani, Noriko, Horiike, Atsushi, Horinouchi, Hidehito, Fujiwara, Yutaka, Nokihara, Hiroshi, Yamamoto, Noboru, Nishio, Makoto, Ohe, Yuichiro, Hosomi, Yukio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Clinical Cancer Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7571815/
https://ncbi.nlm.nih.gov/pubmed/32813912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3385
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller